** Shares of Marlboro maker Altria MO.N up 1.5% at $59.11 in early trade
** Co beats estimates for Q1 sales and profit, helped by rising demand for its smoking alternatives, such as on! nicotine pouches and NJOY vapes
** However, flags an $873 million impairment at its e-cigarette business, where shipments dropped 70% amid a patent dispute
** Co also reiterates its annual adjusted EPS forecast of a 2% to 5% increase, compared with rebased figures for 2024
** Up to last close, stock has risen ~11% YTD
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.